Bluebird Bio Inc. buy Barclays PLC
Start price
31.12.24
/
50%
€0.37
Target price
31.12.25
€38.48
Performance (%)
-
End price
03.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target raised by analysts at Barclays PLC from $2.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten